Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01166308 : Carbon Ion Radiotherapy for Recurrent Gliomas
PhasePhase 1/Phase 2
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- unifocal, supratentorial recurrent glioma

- contrast enhancement on T1-weighted MRI and/or Amino-Acid-PET-positive high-grade
tumor areas

- indication re-irradiation

- age ? 18 years of age

- Karnofsky Performance Score ?60

- For women with childbearing potential, (and men) adequate contraception.

- Ability of subject to understand character and individual consequences of the
clinical trial

- Written informed consent (must be available before enrolment in the trial)

Exclusion Criteria:

- Multifocal Glioma or Gliomatosis cerebri

- refusal of the patients to take part in the study

- previous re-irradiation or prior radiosurgery or prio treatment with interstitial
radioactive seeds

- time interval of < 6 months after primary radiotherapy

- Patients who have not yet recovered from acute toxicities of prior therapies

- Known carcinoma < 5 years ago (excluding Carcinoma in situ of the cervix, basal cell
carcinoma, squamous cell carcinoma of the skin) requiring immediate treatment
interfering with study therapy

- Pregnant or lactating women

- Participation in another clinical study or observation period of competing trials,
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557